Testing effectiveness (Phase 2)Study completedNCT02028364What this trial is testingPet Imaging as a Biomarker in Hormone Refractory postmenopausaL WomenWho this might be right forBreast Cancer Jules Bordet Institute 55
Testing effectiveness (Phase 2)Looking for participantsNCT05868226What this trial is testingPRE-ISPY Phase I/II Oncology Platform ProgramWho this might be right forHER2-positive Breast CancerMetastatic CancerMetastatic Breast Cancer+29 more QuantumLeap Healthcare Collaborative 280
Not applicableNot Yet RecruitingNCT05980208What this trial is testingA Real-world Study of Inetetamab for First-line Treatment of MBCWho this might be right forBreast CancerReal-world Study Hunan Cancer Hospital 150
Early research (Phase 1)Ended earlyNCT06878248What this trial is testingAssess CLBR001+ABBV-461 in Subjects With Locally Advanced or Metastatic Breast CancerWho this might be right forBreast Cancer MetastaticLocally Advanced Breast Cancer (LABC)Malignant Neoplasm of Breast+3 more Calibr, a division of Scripps Research 10
Early research (Phase 1)Study completedNCT03251378What this trial is testingA Multi-Center, Open-Label Study of Fruquintinib in Solid Tumors and Colorectal, and Breast CancersWho this might be right forAdvanced Solid TumorsMetastatic Colon CancerMetastatic Breast Cancer+4 more Hutchison Medipharma Limited 129
Large-scale testing (Phase 3)Study completedNCT03262935What this trial is testingSYD985 vs. Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer Byondis B.V. 437
Early research (Phase 1)Active Not RecruitingNCT04692831What this trial is testingTesting a New Imaging Agent to Identify CancerWho this might be right forHER-2 Positive Malignant Carcinoma of BreastHER-2 Protein OverexpressionHER2-positive Metastatic Breast Cancer Memorial Sloan Kettering Cancer Center 60
Testing effectiveness (Phase 2)Ended earlyNCT01934894What this trial is testingCabazitaxel Plus Lapatinib as Therapy for HER2-Positive Metastatic Breast Cancer Patients With Intracranial MetastasesWho this might be right forMetastatic Breast Cancer With Intracranial Metastases SCRI Development Innovations, LLC 11
Early research (Phase 1)Ended earlyNCT01238029What this trial is testingDose Finding Study for Combination of Capecitabine, Lapatinib and Vinorelbine in Metastatic Breast CancerWho this might be right forMetastatic Breast CancerHER2 PositiveFirst or Second Line Therapy+1 more Sponsor GmbH 12
Large-scale testing (Phase 3)UnknownNCT03863223What this trial is testingPyrotinib in Combination With Trastuzumab and Docetaxel in Patients With HER2 Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer Jiangsu HengRui Medicine Co., Ltd. 590
Testing effectiveness (Phase 2)Looking for participantsNCT04923542What this trial is testingSRS & Abemaciclib w/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain MetastasesWho this might be right forBrain MetastasesHR+ Metastatic Breast Cancer H. Lee Moffitt Cancer Center and Research Institute 31
Not applicableStudy completedNCT06676436What this trial is testingObservational Study on the Treatment of Patients With Metastatic Breast CancerWho this might be right forCancer AstraZeneca 204
Testing effectiveness (Phase 2)Study completedNCT00773344What this trial is testingClinical Trial of the Combination of Trastuzumab (Herceptin) and Tanespimycin in Patients With Solid Tumors and Her2 Positive Metastatic Breast Cancer That Have Previously Failed HerceptinWho this might be right forSolid TumorsBreast Cancer Bristol-Myers Squibb 25
Testing effectiveness (Phase 2)Looking for participantsNCT06450314What this trial is testingDecreasing Treatment for Metastatic HER2-Positive Breast Cancer With Undectable Cancer Levels in Blood Tests.Who this might be right forMetastatic Breast CancerHER2-positive Breast Cancer UNICANCER 170
Not applicableEnded earlyNCT00358098What this trial is testingStudy to Determine the Utility of FES-PET and FDG-PET in the Prediction of Response to Hormone Therapy in Women With Estrogen Positive Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer AHS Cancer Control Alberta 51
Large-scale testing (Phase 3)UnknownNCT05861830What this trial is testingDalpiciclib With Endocrine Therapy for Advanced Breast Cancer After CDK4/6 Inhibitor Failure (DAWNA-FES)Who this might be right forAdvanced Breast Cancer Peking Union Medical College Hospital 80
Not applicableStudy completedNCT04460898What this trial is testingRW Treatment Patterns and Outcomes in Postmenopausal HR+/HER2- mBC Patients Treated With Palbociclib Plus Letrozole as Initial Endocrine Therapy at Community Oncology Practices in the U.S.Who this might be right forBreast Cancer Pfizer 195
Not applicableStudy completedNCT07108595What this trial is testingEfficacy and Safety of T-DXd in Patients With HER2-positive and HER2-low Metastatic Breast Cancer: a Real-world StudyWho this might be right forBreast Cancer The First Affiliated Hospital with Nanjing Medical University 142
Post-approval studies (Phase 4)UnknownNCT04767828What this trial is testingA Single Arm Study of Brain Metastasis in Patients With HER2-positive Breast CancerWho this might be right forTTP Tianjin Medical University Cancer Institute and Hospital 43
Early research (Phase 1)Ended earlyNCT02964507What this trial is testingDose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Participants With Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Advanced or Metastatic Breast CancerWho this might be right forNeoplasms GlaxoSmithKline 124